Mitomycin C → Mitomycin C

HRID 734192

반응식

HRID 734192 반응식
[CH3:1][C:2]1[C:8](=[O:9])[C:7]2[N:10]3[C@@:14]([O:21][CH3:22])([C@H:15]([CH2:16][O:17][C:18]([NH2:20])=[O:19])[C:6]=2[C:4](=[O:5])[C:3]=1[NH2:24])[C@H:13]1[NH:23][C@H:12]1[CH2:11]3>CN(C)C=O>[CH3:1][C:2]1[C:8](=[O:9])[C:7]2[N:10]3[C@@:14]([O:21][CH3:22])([C@H:15]([CH2:16][O:17][C:18]([NH2:20])=[O:19])[C:6]=2[C:4](=[O:5])[C:3]=1[NH2:24])[C@H:13]1[NH:23][C@H:12]1[CH2:11]3.[CH3:7][N:10]([C:14]1[CH:15]=[CH:6][CH:4]=[CH:3][N:24]=1)[CH3:11]

참가 물질

4

반응물 1

HCID 5746Mitomycin C

생성물 2

HCID 5746Mitomycin CHCID 218852-Dimethylaminopyridine

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

A solution of mitomycin C (MMC, 0.35 mmol), dimethylaminopyridine (0.1 mmol) and dimethylformamide (DMF, 2 mL) was prepared. The MMC solution was slowly added to the acyl chloride solution. After overnight reaction, the methylene chloride was evaporated off and the crude product was recovered by addition of isopropanol followed by filtration. The mPEG-DTB-MMC conjugate was further purified by two precipitation from ethanol. Yield: 3.4 g. The MMC content (≈90%) was determined by UV. The conjugate was further characterized by 1H NMR (360 MHz, CDCl3): δ 1.18 (d, J=7.5, 3H), 1.76 (s, 3H), 2.96-3.03 (m, 3H), 3.19 (s, 3H), 3.29 (dd, J=4.7 and 2.9 Hz, 1H), 3.41 (dd, J=5.0 and 2.2 Hz, 1H), 3.48 (dd, J=13.7 and 2.5 Hz, 1H), 3.60 (s, PEG, 1000H), 4.15 (t, OCOCH2, 2H), 4.27-4.36 (m, 2H), 4.43 (d, J=13.3 Hz, 1H), 4.61 (s, 2H), 4.90 (ddd, J=10.4 and 5.0 and 2.2 Hz, 1H), 5.00 (s, 2H), 7.32 (d, J=8.6 Hz, 2H), 7.50 (d, J=7.9 Hz, 2H).

후처리

  1. customAfter overnight reaction
  2. customthe methylene chloride was evaporated off
  3. customthe crude product was recovered by addition of isopropanol
  4. filtrationfollowed by filtration
  5. customThe mPEG-DTB-MMC conjugate was further purified by two precipitation from ethanol

출처 및 근거

ORD 기록
ord-209613fc092f499ea4e11f5eb77e9dd3
출처 데이터셋
uspto-grants-2009_09
특허 번호
US07592307B2

연결된 노트

불러오는 중…